Tackling Healthcare Disparities for Historically Overlooked Patients With Multiple Myeloma | Registration
earn up to 4.0 ACCME credits for all 4 live activities
Register
About The Program
Overview
Learning Objectives
CME/ Information
Faculty and Disclosures
Instructions
Program Overview
Racial and ethnic disparities in multiple myeloma (MM) impact outcomes, with Black patients facing higher incidence, poorer survival, and less access to advanced treatments. Many healthcare providers lack awareness of these inequities and the importance of culturally competent shared decision-making (SDM). Educational programs focused on SDM, cultural competence, and team-based care are essential to reduce disparities and improve outcomes for all MM patients.
Target Audience
This educational program is directed toward hematologists/oncologists in both the academic and community setting as well as advanced practice providers and other HCPs involved in the management of patients with MM.
Supporter Acknowledgement
This educational activity is supported by independent educational grants from GSK and Janssen Biotech, Inc administered by Janssen Scientific Affairs, LLC.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- DESCRIBE racial and ethnic factors in patients with MM that affect incidence, disease characteristics, progression, and patient survival.
- IDENTIFY disparities in MM care and access to novel treatments among underserved populations.
- OUTLINE treatment plans incorporating collaborative SDM that address social and cultural norms, health literacy needs, and build trust in the patient-clinician relationship.
- IMPLEMENT team-based strategies to mitigate healthcare disparities in MM, focusing on equitable access to emerging therapies and patient-centered care.
Accredited Provider
This activity is jointly provided by Global Education Group and Iridium Continuing Education.


Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 4.0 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity for 4.0 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Iridium CE do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Joseph Mikhael, MD, Med, FRCPC, FACP, FASCO
Professor, Translational Genomics Research Institute - City of Hope Cancer Center,
Chief Medical Officer - International Myeloma Foundation
Chief Medical Officer - International Myeloma Foundation
Consulting Fee (e.g., Advisory Board):
Amgen, BMS, Janssen, Menarini, Sanofi
Amgen, BMS, Janssen, Menarini, Sanofi
Jorge Monge Urrea, MD
Assistant Professor of Medicine, University of Colorado
Consulting Fee (e.g., Advisory Board):
Johnson & Johnson, Pfizer
Johnson & Johnson, Pfizer
Dan Sherbenou, MD, PhD
Consulting Fee (e.g., Advisory Board):
Kelly Sidor, MSN
ACNP-BC
Consulting Fee (e.g., Advisory Board):
The planners and managers have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at Iridium CE have no relevant financial relationships to disclose.
The planners and managers at Iridium CE have no relevant financial relationships to disclose.
Virtual Mentorship
Tackling Healthcare Disparities for Historically Overlooked Patients With Multiple Myeloma
Thank you!
You have successfully registered for our Multiple Myeloma Virtual Mentorship Program.
We look forward to seeing you there.
What to expect
- Interactive Discussions
- Peer Learning
- Feedback and Guidance
- Confidence Building
- Teaching Moments
- Networking and Collaboration
Target Audience
This educational program is directed toward hematologists/oncologists in both the academic and community setting as well as advanced practice providers and other HCPs involved in the management of patients with MM.
Dates
April 16, 2025 1pm ET / 12pm CT / 11am MT / 10am PT
Upon completion of this activity, the participant should be able to:
- DESCRIBE racial and ethnic factors in patients with MM that affect incidence, disease characteristics, progression, and patient survival.
1 AMA PRA Category 1 Credit
1.0 ANCC Credit
April 30, 2025 1pm ET / 12pm CT / 11am MT / 10am PT
Upon completion of this activity, the participant should be able to:
- IDENTIFY disparities in MM care and access to novel treatments among underserved populations.
1 AMA PRA Category 1 Credit
1.0 ANCC Credit
May 7, 2025 1pm ET / 12pm CT / 11am MT / 10am PT
Upon completion of this activity, the participant should be able to:
- OUTLINE treatment plans incorporating collaborative SDM that address social and cultural norms, health literacy needs, and build trust in the patient-clinician relationship.
1 AMA PRA Category 1 Credit
1.0 ANCC Credit
May 21, 2025 1pm ET / 12pm CT / 11am MT / 10am PT
Upon completion of this activity, the participant should be able to:
- IMPLEMENT team-based strategies to mitigate healthcare disparities in MM, focusing on equitable access to emerging therapies and patient-centered care.
1 AMA PRA Category 1 Credit
1.0 ANCC Credit
Location
Zoom
About the Virtual Mentorship
Racial and ethnic disparities in multiple myeloma (MM) significantly impact patient outcomes, with Black patients experiencing higher incidence rates, poorer survival, and reduced access to advanced treatments. Many healthcare providers are unaware of these inequities and the critical role of culturally competent shared decision-making (SDM) in improving care.
In partnership with CU Hematology, our live virtual mentorship program offers an interactive learning experience led by expert faculty. This initiative provides healthcare providers with the knowledge and skills to implement SDM, enhance cultural competence, and foster team-based care. Through mentorship, case discussions, and real-world insights, we aim to equip participants with actionable strategies to reduce disparities and improve outcomes for all MM patients.
In partnership with CU Hematology, our live virtual mentorship program offers an interactive learning experience led by expert faculty. This initiative provides healthcare providers with the knowledge and skills to implement SDM, enhance cultural competence, and foster team-based care. Through mentorship, case discussions, and real-world insights, we aim to equip participants with actionable strategies to reduce disparities and improve outcomes for all MM patients.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must:
- Read the learning objectives and faculty disclosures
- Complete the pretest
- View the broadcast
- Complete the posttest with a score of 70% or higher
A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com
System Requirements



This educational activity is supported by independent educational grants from GSK and Janssen Biotech, Inc administered by Janssen Scientific Affairs, LLC.
Maximum Credit Amount: 4.00
Credit Type: ACCME, ANCC
Release: 04/16/2025
Expiration: 05/21/2025

Copyright © 2024


Stay Informed
To receive updates as soon as the new dates are confirmed, please share your email.
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
Thank you!